VANCOUVER, Feb. 13, 2019 /PRNewswire/ – 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF) (FWB: 1QF) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD wellness products, is pleased to report that its subsidiary, Infused MFG. (“Infused”), continues to expand its reach across the United States and has attained product distribution into 46 states.
Infused, a manufacturer of proprietary hemp-based, CBD infused health and wellness products continues its market penetration in the U.S., where it has established its own distribution to over 600 stores. Infused’s recognized brands, including Canna Hemp™, Canna Hemp X™, and Canna Hemp Paws™ are available in over 250 retail stores in California, Nevada, Arizona, and Colorado, with the remainder distributed across the U.S. In addition, the Company has an established e-commerce presence, sales agents, call-centre, and a dedicated sales and marketing team who work directly with each retailer, building and maintaining relationships, providing customer service and education.
“Owning our distribution is key to our growth strategy and to our success, ensuring that our branding and messaging is properly delivered”, said Mr. Chris Rebentisch, USA Chief Operating Officer. “Our operational expertise and excellence have set the benchmark for product manufacturing, distribution and compliance in Nevada.”
All production is fully integrated in-house, with proprietary chemical-free formulas, containing non-GMO, organic ingredients and real cannabis-derived terpenes. The Company has established high standards by which CBD is formulated and all products are tripled tested – internally, independently by a certified laboratory for quality assurance and then re-tested. The Company’s exclusive nanoparticle technology for maximum bioavailability aids in better absorption and effectiveness.
The recently adopted Agriculture Improvement Act of 2018 (“Farm Bill”), which legalized hemp as an agricultural commodity federally in the United States, is bringing renewed focus on the hemp-CBD industry, which